ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0LB2 Supernus Pharmaceuticals Inc

55.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 215M302.24M408.9M392.76M520.4M586.31M667.75M609.04M
Operating Income 54.22M99.54M144.44M148.57M173.7M86.03M46.12M-5.27M
Pre Tax Income 50.37M100.62M140.18M147.49M168.65M73.18M60.74M2.77M
Net Income 91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.8251.1162.1222.1522.4011.0031.1190.024
EBIT 53.53M99.25M144.44M148.57M173.7M86.03M46.12M-5.27M
EBITDA 56.62M107.64M151.54M155.23M193.7M118.62M131.67M99.78M

Your Recent History

Delayed Upgrade Clock